These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 13388837)

  • 1. [Prothrombin time and heparin time during pelentan therapy].
    CERMAK L; HOBZA A; POKORNY J
    Pol Tyg Lek (Wars); 1956 Sep; 11(37):1577-8. PubMed ID: 13388837
    [No Abstract]   [Full Text] [Related]  

  • 2. [Various current problems associated with anticoagulant therapy using Pelentan].
    Donner L; Klener P
    Vnitr Lek; 1977 Sep; 23(9):880-6. PubMed ID: 919363
    [No Abstract]   [Full Text] [Related]  

  • 3. [Method of prothrombin time test in the control of pelentan therapy].
    LIBANSKY J; DIENSTBIER Z; POLAK B
    Prakt Lek; 1951 Aug; 31(16):353-5. PubMed ID: 14875628
    [No Abstract]   [Full Text] [Related]  

  • 4. [Modification of prothrombin time during storage of normal rabbit plasma and with added pelentan].
    TRCKA V; HOLUBOVA E; MACOVA S; HORAKOVA Z
    Cas Lek Cesk; 1951 Nov; 90(48):1435-7. PubMed ID: 14887003
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of heparin and pelentan on the biopolymer metabolism of connective tissue in myocardial infarct].
    Sharaev PN; Leshchinskiĭ LA; Pimenov LT; Vtorov AE
    Farmakol Toksikol; 1984; 47(1):44-6. PubMed ID: 6705903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Control of anticoagulant therapy with Pelentan. Results of the work of 20 laboratories].
    Vorlová Z; Sikorová J
    Cas Lek Cesk; 1982 Dec; 121(49):1515-7. PubMed ID: 7151121
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anticoagulant therapy in Paget-Schroetter syndrome].
    KARSAY G; KORANYI A
    Orv Hetil; 1956 Sep; 97(37):1027-8. PubMed ID: 13388322
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of pelentan (ethyl dihydroxycumarinylacetate) on the level of some blood coagulation factors in relation to age].
    Nerad V; Chrobák L; Skaunic V; Hassmanová V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1966; 9(4):605-8. PubMed ID: 5226690
    [No Abstract]   [Full Text] [Related]  

  • 9. [At the present level of anticoagulation therapy with Pelentan, is it possible to expect effective prevention of thromboembolism?].
    Krislo V; Sorf M; Krislová M
    Vnitr Lek; 1985 Aug; 31(8):806-9. PubMed ID: 4036034
    [No Abstract]   [Full Text] [Related]  

  • 10. [Reaction determining blood prothrombin activity and control of pelentan therapy from the practical viewpoint].
    LIBANSKY J; DIENSTBIER Z; POLAK B
    Cas Lek Cesk; 1951 Aug; 90(35):1039-45. PubMed ID: 14879385
    [No Abstract]   [Full Text] [Related]  

  • 11. [Control of anticoagulation therapy with Pelentan. Results of the 2nd working study of 37 laboratories].
    Vorlová Z; Sikorová J
    Cas Lek Cesk; 1983 Dec; 122(51):1569-72. PubMed ID: 6652671
    [No Abstract]   [Full Text] [Related]  

  • 12. The value of anticoagulant therapy in the treatment of acute myocardial infarction.
    McCLUSKIE JA; SEATON DA
    Scott Med J; 1959 Jun; 4(6):305-9. PubMed ID: 13668583
    [No Abstract]   [Full Text] [Related]  

  • 13. Anticoagulant therapy with tromexan and marcoumar and determination of the prothrombin-proconvertin activity by a micro-method.
    IVERSEN T
    Acta Med Scand; 1956 Sep; 155(3):161-70. PubMed ID: 13361829
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of anticoagulant therapy in focal ischemic cerebrovascular disease: further observations.
    Siekert RG
    Res Publ Assoc Res Nerv Ment Dis; 1966; 41():359-66. PubMed ID: 4163329
    [No Abstract]   [Full Text] [Related]  

  • 15. [Total mesenteric infarct caused by thrombosis of the mesenteric vein; cure with anti-coagulant therapy].
    DE THOMASSON
    Mem Acad Chir (Paris); 1956 Oct 7-Nov 31; 82(27-28):843-5. PubMed ID: 13386922
    [No Abstract]   [Full Text] [Related]  

  • 16. [Our experiences with long-term treatment with Pelentan in myocardial infarct].
    Argalás K; Rysavý F
    Vnitr Lek; 1968 Mar; 14(3):283-90. PubMed ID: 5638966
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anticoagulant therapy of a case of priapism].
    MARAGNANI U
    Minerva Urol; 1958; 10(3):67-9. PubMed ID: 13565845
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pelentan substances in breast milk and their paradox effect on prothrombin].
    GOSTOF R; HOMOLKA J; ZELENKA J
    Pediatr Listy; 1950; 5(4):225-7. PubMed ID: 14775995
    [No Abstract]   [Full Text] [Related]  

  • 19. [Correlation of pelentan metabolites in blood prothrombin in hepatitic and vascular diseases].
    KORBELAR O
    Cas Lek Cesk; 1950 May; 89(19):540-3. PubMed ID: 15420742
    [No Abstract]   [Full Text] [Related]  

  • 20. [Estimation of pelentan disintegration in blood].
    KORBELAR O
    Cas Lek Cesk; 1950 Apr; 89(16):447-9. PubMed ID: 15414522
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.